Captive-Bred Slender-Billed Vultures Take First Flight Into the Wild in Assam

The 2007 Bet That Just Paid Off: Reading the Vulture

Release as a Full-Cycle Test The headline event is a single afternoon: ten birds released from an aviary in Biswanath. But the target this event should be measured against isn't "a release happened"

• it's a 2007 commitment: build a breeding programme capable of rebuilding a species population from near-zero and eventually reintroducing it to the wild. The data on where that commitment stands is now, for the first time, actual field evidence rather than captive-breeding statistics.

What the Target Actually Required Reversing a 99

percent population crash caused by diclofenac poisoning required three sequential steps, each of which had to work before the next could be attempted: remove the toxin from the food chain (the 2006 diclofenac ban, later extended to ketoprofen and aceclofenac), rebuild a breeding population in captivity from the surviving genetic stock (the Vulture Conservation Breeding Centres, including Rani, established in 2007) and then prove that captive-bred birds could actually survive reintegration into a wild ecosystem.

Most conservation programmes stall at step two - captive populations grow, funding runs out or attention moves elsewhere and the birds never leave the aviary. This release is the first hard evidence that step three is achievable for the slender-billed vulture specifically, anywhere in the world.

Where the Real Test Still Lies Ahead

The soft-release method used here - three months of acclimatisation in a release aviary before full freedom, allowing the birds to observe wild scavengers and adjust to the Kaziranga ecosystem - is designed precisely to reduce the failure risk at this final, hardest step.

But the genuine test of the 2007 bet isn't the release itself; it's whether these ten birds survive, forage successfully and eventually breed in the wild over the coming years. A release that isn't followed by post-release monitoring, satellite tracking and survival data collection would answer only "can we get captive-bred vultures airborne," not "did we actually rebuild a self-sustaining population"

• and the second question is the one the entire programme exists to answer. There's also a structural vulnerability worth naming: this recovery model only holds if the underlying cause - NSAID contamination of livestock carcasses - stays controlled. Diclofenac's veterinary ban has held since 2006, but the expansion to ketoprofen and aceclofenac shows new toxic substitutes keep surfacing. A release into an environment where the original poisoning mechanism could re-emerge through a new drug is a release into ongoing risk, not a resolved threat. For an aspirant, the exam-relevant framing is this: ex-situ conservation success is not measured at the point captive breeding numbers rise - it's measured at the point those individuals demonstrably survive and reproduce in the wild they were bred to return to. This release is the moment that measurement finally becomes possible for the slender-billed vulture, not the moment the programme's success is confirmed.